English

PHARMACYCLICS INC

EDGAR

Quarterly report (10-Q) · filed 2015-05-04

89 filing records in this dataset, filed from 1996-05-13 to 2015-05-04. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

206 million USD

2015 Q3 · USD

Exact inputs and evidence

Revenue: 205772000 USD Source

Operating margin

1.84%

2015 Q3 · %

Exact inputs and evidence

Operating Income: 3781000 USD Source
Revenue: 205772000 USD Source

Operating cash flow

-4.92 million USD

2015 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -4919000 USD Source

Free cash flow

-6.04 million USD

2015 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -4919000 USD Source
Capital Expenditure: 1119000 USD Source

Cash and cash equivalents: 875 million USD 2015-03-31 Source
Exact value

874684000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 76.8 million shares 2015-03-31 Source
Exact value

76791635 shares

Reported share-count change

2.35% · 1.77 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

75025090 shares · 2014-03-31· Source
76791635 shares · 2015-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

816 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Revenue: 113020000 USD · 2014-04-01 – 2014-06-30 Source
Revenue: 207140000 USD · 2014-07-01 – 2014-09-30 Source
Revenue: 290192000 USD · 2014-10-01 – 2014-12-31 Source
Revenue: 205772000 USD · 2015-01-01 – 2015-03-31 Source

Net income

72 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Net income: -37057000 USD · 2014-04-01 – 2014-06-30 Source
Net income: 41422000 USD · 2014-07-01 – 2014-09-30 Source
Net income: 63484000 USD · 2014-10-01 – 2014-12-31 Source
Net income: 4147000 USD · 2015-01-01 – 2015-03-31 Source

Operating cash flow

123 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Operating cash flow: 48279000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: 55460000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: 93836000 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: 48279000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: 183767000 USD · 2014-01-01 – 2014-12-31 Source
Operating cash flow: 93836000 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -4919000 USD · 2015-01-01 – 2015-03-31 Source

Capital expenditure

8.83 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Capital expenditure: 9661000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 6211000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 11662000 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 9661000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 13919000 USD · 2014-01-01 – 2014-12-31 Source
Capital expenditure: 11662000 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 1119000 USD · 2015-01-01 – 2015-03-31 Source

Free cash flow

115 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Operating cash flow: 48279000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: 55460000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: 93836000 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: 48279000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: 183767000 USD · 2014-01-01 – 2014-12-31 Source
Operating cash flow: 93836000 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -4919000 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 9661000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 6211000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 11662000 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 9661000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 13919000 USD · 2014-01-01 – 2014-12-31 Source
Capital expenditure: 11662000 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 1119000 USD · 2015-01-01 – 2015-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-05-04.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2014-12-31
Operating income: 11 of 11 periods available· newest 2014-12-31
Net income: 11 of 11 periods available· newest 2014-12-31
Operating cash flow: 11 of 11 periods available· newest 2014-12-31
Capital expenditure: 11 of 11 periods available· newest 2014-12-31
Total assets: 6 of 11 periods available· newest 2014-12-31
Total liabilities: 11 of 11 periods available· newest 2014-12-31
Current assets: 11 of 11 periods available· newest 2014-12-31
Current liabilities: 11 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2014-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+180.5%

Prior period

USD 260.17 million

2013-01-01 – 2013-12-31
Current period

USD 729.73 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

729729000 − 260169000 = 469560000 USD

260169000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
729729000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Year-over-year change in Revenue: 469560000 USD Concept: fundies:Revenue Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 729729000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#463453 Filing: 000162828015000826 Input fundies:Revenue: 260169000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#461118 Filing: 000162828015000826
The citation records this snapshot. The page link may show a newer release later.
Net income
+28.5%

Prior period

USD 67.01 million

2013-01-01 – 2013-12-31
Current period

USD 86.12 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

86124000 − 67010000 = 19114000 USD

67010000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
86124000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Year-over-year change in Net income: 19114000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 86124000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#421057 Filing: 000162828015000826 Input fundies:NetIncome: 67010000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#420069 Filing: 000162828015000826
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+107%

Prior period

USD 88.77 million

2013-01-01 – 2013-12-31
Current period

USD 183.77 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

183767000 − 88772000 = 94995000 USD

88772000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
183767000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Year-over-year change in Operating cash flow: 94995000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 183767000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#418315 Filing: 000162828015000826 Input fundies:OperatingCashFlow: 88772000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#418104 Filing: 000162828015000826
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-24%

Prior period

USD 18.32 million

2013-01-01 – 2013-12-31
Current period

USD 13.92 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

13919000 − 18318000 = -4399000 USD

18318000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
13919000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Year-over-year change in Capital expenditure: -4399000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13919000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433556 Filing: 000162828015000826 Input fundies:CapitalExpenditure: 18318000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433345 Filing: 000162828015000826
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2014-01-01 – 2014-12-31

Revenue USD 729.73 million 100% of revenue
Cost of revenue USD 40.41 million 5.5% of revenue
Operating expenses USD 340.41 million 47% of revenue
Other operating costs Derived USD 226.52 million 31% of revenue
Operating income USD 122.38 million 17% of revenue
Tax, interest and other Derived USD 36.26 million 5% of revenue
Net income USD 86.12 million 12% of revenue

Cash

Operating cash flow USD 183.77 million 25% of revenue
Capital expenditure USD 13.92 million 1.9% of revenue
Free cash flow Derived USD 169.85 million 23% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Not shown: operating income or net income is not reported.
2006 Operating loss: operating costs were 24,477% of revenue.
2007 Operating loss: operating costs were 22,633% of revenue.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Operating loss: operating costs were 268% of revenue.
2011 Operating loss: operating costs were 530% of revenue.
2012 Net income was higher than operating income, so the split is not drawn.
2014 26%12%62%
2015 12%83%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2004-09-13 – 2005-09-12	0	32869000 Derived	-32869000	-1821000 Derived	-31048000	-30224000 Derived	Source 2004-09-13 – 2005-09-12: 0 USD Inspect Revenue Open source 2004-09-13 – 2005-09-12: -32869000 USD Inspect Operating Income Open source 2004-09-13 – 2005-09-12: -31048000 USD Inspect Net Income Open source 2004-09-13 – 2005-09-12: -29930000 USD Inspect Operating Cash Flow Open source 2004-09-13 – 2005-09-12: 294000 USD Inspect Capital Expenditure Open source
2006 2005-07-01 – 2006-06-30	181000	44303000 Derived	-44122000	-1964000 Derived	-42158000	-32287000 Derived	Source 2005-07-01 – 2006-06-30: 181000 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: -44122000 USD Inspect Operating Income Open source 2005-07-01 – 2006-06-30: -42158000 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: -31819000 USD Inspect Operating Cash Flow Open source 2005-07-01 – 2006-06-30: 468000 USD Inspect Capital Expenditure Open source
2007 2006-07-01 – 2007-06-30	126000	28518000 Derived	-28392000	-2175000 Derived	-26217000	-24068000 Derived	Source 2006-07-01 – 2007-06-30: 126000 USD Inspect Revenue Open source 2006-07-01 – 2007-06-30: -28392000 USD Inspect Operating Income Open source 2006-07-01 – 2007-06-30: -26217000 USD Inspect Net Income Open source 2006-07-01 – 2007-06-30: -23544000 USD Inspect Operating Cash Flow Open source 2006-07-01 – 2007-06-30: 524000 USD Inspect Capital Expenditure Open source
2008 2007-07-01 – 2008-06-30	0	25512000 Derived	-25512000	-1214000 Derived	-24298000	-22292000 Derived	Source 2007-07-01 – 2008-06-30: 0 USD Inspect Revenue Open source 2007-07-01 – 2008-06-30: -25512000 USD Inspect Operating Income Open source 2007-07-01 – 2008-06-30: -24298000 USD Inspect Net Income Open source 2007-07-01 – 2008-06-30: -22105000 USD Inspect Operating Cash Flow Open source 2007-07-01 – 2008-06-30: 187000 USD Inspect Capital Expenditure Open source
2009 2008-07-01 – 2009-06-30	0	22428000 Derived	-22428000	1019000 Derived	-23447000	-8256000 Derived	Source 2008-07-01 – 2009-06-30: 0 USD Inspect Revenue Open source 2008-07-01 – 2009-06-30: -22428000 USD Inspect Operating Income Open source 2008-07-01 – 2009-06-30: -23447000 USD Inspect Net Income Open source 2008-07-01 – 2009-06-30: -8175000 USD Inspect Operating Cash Flow Open source 2008-07-01 – 2009-06-30: 81000 USD Inspect Capital Expenditure Open source
2010 2009-07-01 – 2010-06-30	9307000	24919000 Derived	-15612000	-588000 Derived	-15024000	-15692000 Derived	Source 2009-07-01 – 2010-06-30: 9307000 USD Inspect Revenue Open source 2009-07-01 – 2010-06-30: -15612000 USD Inspect Operating Income Open source 2009-07-01 – 2010-06-30: -15024000 USD Inspect Net Income Open source 2009-07-01 – 2010-06-30: -15468000 USD Inspect Operating Cash Flow Open source 2009-07-01 – 2010-06-30: 224000 USD Inspect Capital Expenditure Open source
2011 2010-07-01 – 2011-06-30	8233000	43607000 Derived	-35374000	-171000 Derived	-35203000	-23421000 Derived	Source 2010-07-01 – 2011-06-30: 8233000 USD Inspect Revenue Open source 2010-07-01 – 2011-06-30: -35374000 USD Inspect Operating Income Open source 2010-07-01 – 2011-06-30: -35203000 USD Inspect Net Income Open source 2010-07-01 – 2011-06-30: -22271000 USD Inspect Operating Cash Flow Open source 2010-07-01 – 2011-06-30: 1150000 USD Inspect Capital Expenditure Open source
2012 2011-07-01 – 2012-06-30	81990000	70112000 Derived	11878000	-108000 Derived	11986000	83112000 Derived	Source 2011-07-01 – 2012-06-30: 81990000 USD Inspect Revenue Open source 2011-07-01 – 2012-06-30: 11878000 USD Inspect Operating Income Open source 2011-07-01 – 2012-06-30: 11986000 USD Inspect Net Income Open source 2011-07-01 – 2012-06-30: 86087000 USD Inspect Operating Cash Flow Open source 2011-07-01 – 2012-06-30: 2975000 USD Inspect Capital Expenditure Open source
2014 2013-01-01 – 2013-12-31	260169000	162245000 Derived	97924000	30914000 Derived	67010000	70454000 Derived	Source 2013-01-01 – 2013-12-31: 260169000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 97924000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 67010000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 88772000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 18318000 USD Inspect Capital Expenditure Open source
2015 2014-01-01 – 2014-12-31	729729000	607348000 Derived	122381000	36257000 Derived	86124000	169848000 Derived	Source 2014-01-01 – 2014-12-31: 729729000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 122381000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 86124000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 183767000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 13919000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 729.7M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-09-12	Revenue	0	Revenue: 0 Open source
20062006-06-30	Revenue	181000	Revenue: 181000 Open source
20072007-06-30	Revenue	126000	Revenue: 126000 Open source
20082008-06-30	Revenue	0	Revenue: 0 Open source
20092009-06-30	Revenue	0	Revenue: 0 Open source
20102010-06-30	Revenue	9307000	Revenue: 9307000 Open source
20112011-06-30	Revenue	8233000	Revenue: 8233000 Open source
20122012-06-30	Revenue	81990000	Revenue: 81990000 Open source
20142013-12-31	Revenue	260169000	Revenue: 260169000 Open source
20152014-12-31	Revenue	729729000	Revenue: 729729000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

180.5% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-09-12	Year over year	No prior comparable period	Revenue: 0 Open source
20062006-06-30	Year over year	No prior comparable period	Revenue: 181000 Open source Revenue: 0 Open source
20072007-06-30	Year over year	-30.4%	Revenue: 126000 Open source Revenue: 181000 Open source
20082008-06-30	Year over year	-100%	Revenue: 0 Open source Revenue: 126000 Open source
20092009-06-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-06-30	Year over year	No prior comparable period	Revenue: 9307000 Open source Revenue: 0 Open source
20112011-06-30	Year over year	-11.5%	Revenue: 8233000 Open source Revenue: 9307000 Open source
20122012-06-30	Year over year	895.9%	Revenue: 81990000 Open source Revenue: 8233000 Open source
20142013-12-31	Year over year	No prior comparable period	Revenue: 260169000 Open source
20152014-12-31	Year over year	180.5%	Revenue: 729729000 Open source Revenue: 260169000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 16.8% 2015

Net margin 11.8% 2015

Free cash flow margin 23.3% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-09-12	Operating margin	Not reported	Operating Income: -32869000 Open source Revenue: 0 Open source
20062006-06-30	Operating margin	-24,376.8%	Operating Income: -44122000 Open source Revenue: 181000 Open source
20072007-06-30	Operating margin	-22,533.3%	Operating Income: -28392000 Open source Revenue: 126000 Open source
20082008-06-30	Operating margin	Not reported	Operating Income: -25512000 Open source Revenue: 0 Open source
20092009-06-30	Operating margin	Not reported	Operating Income: -22428000 Open source Revenue: 0 Open source
20102010-06-30	Operating margin	-167.7%	Operating Income: -15612000 Open source Revenue: 9307000 Open source
20112011-06-30	Operating margin	-429.7%	Operating Income: -35374000 Open source Revenue: 8233000 Open source
20122012-06-30	Operating margin	14.5%	Operating Income: 11878000 Open source Revenue: 81990000 Open source
20142013-12-31	Operating margin	37.6%	Operating Income: 97924000 Open source Revenue: 260169000 Open source
20152014-12-31	Operating margin	16.8%	Operating Income: 122381000 Open source Revenue: 729729000 Open source
20052005-09-12	Net margin	Not reported	Net Income: -31048000 Open source Revenue: 0 Open source
20062006-06-30	Net margin	-23,291.7%	Net Income: -42158000 Open source Revenue: 181000 Open source
20072007-06-30	Net margin	-20,807.1%	Net Income: -26217000 Open source Revenue: 126000 Open source
20082008-06-30	Net margin	Not reported	Net Income: -24298000 Open source Revenue: 0 Open source
20092009-06-30	Net margin	Not reported	Net Income: -23447000 Open source Revenue: 0 Open source
20102010-06-30	Net margin	-161.4%	Net Income: -15024000 Open source Revenue: 9307000 Open source
20112011-06-30	Net margin	-427.6%	Net Income: -35203000 Open source Revenue: 8233000 Open source
20122012-06-30	Net margin	14.6%	Net Income: 11986000 Open source Revenue: 81990000 Open source
20142013-12-31	Net margin	25.8%	Net Income: 67010000 Open source Revenue: 260169000 Open source
20152014-12-31	Net margin	11.8%	Net Income: 86124000 Open source Revenue: 729729000 Open source
20052005-09-12	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -29930000 Open source Capital Expenditure: 294000 Open source
20062006-06-30	Free cash flow margin	-17,838.1%	Revenue: 181000 Open source Operating Cash Flow: -31819000 Open source Capital Expenditure: 468000 Open source
20072007-06-30	Free cash flow margin	-19,101.6%	Revenue: 126000 Open source Operating Cash Flow: -23544000 Open source Capital Expenditure: 524000 Open source
20082008-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -22105000 Open source Capital Expenditure: 187000 Open source
20092009-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -8175000 Open source Capital Expenditure: 81000 Open source
20102010-06-30	Free cash flow margin	-168.6%	Revenue: 9307000 Open source Operating Cash Flow: -15468000 Open source Capital Expenditure: 224000 Open source
20112011-06-30	Free cash flow margin	-284.5%	Revenue: 8233000 Open source Operating Cash Flow: -22271000 Open source Capital Expenditure: 1150000 Open source
20122012-06-30	Free cash flow margin	101.4%	Revenue: 81990000 Open source Operating Cash Flow: 86087000 Open source Capital Expenditure: 2975000 Open source
20142013-12-31	Free cash flow margin	27.1%	Revenue: 260169000 Open source Operating Cash Flow: 88772000 Open source Capital Expenditure: 18318000 Open source
20152014-12-31	Free cash flow margin	23.3%	Revenue: 729729000 Open source Operating Cash Flow: 183767000 Open source Capital Expenditure: 13919000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 183.8M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-09-12	Operating cash flow	-29930000	Operating Cash Flow: -29930000 Open source
20062006-06-30	Operating cash flow	-31819000	Operating Cash Flow: -31819000 Open source
20072007-06-30	Operating cash flow	-23544000	Operating Cash Flow: -23544000 Open source
20082008-06-30	Operating cash flow	-22105000	Operating Cash Flow: -22105000 Open source
20092009-06-30	Operating cash flow	-8175000	Operating Cash Flow: -8175000 Open source
20102010-06-30	Operating cash flow	-15468000	Operating Cash Flow: -15468000 Open source
20112011-06-30	Operating cash flow	-22271000	Operating Cash Flow: -22271000 Open source
20122012-06-30	Operating cash flow	86087000	Operating Cash Flow: 86087000 Open source
20142013-12-31	Operating cash flow	88772000	Operating Cash Flow: 88772000 Open source
20152014-12-31	Operating cash flow	183767000	Operating Cash Flow: 183767000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 169.8M 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-09-12	Free cash flow	-30224000	Operating Cash Flow: -29930000 Open source Capital Expenditure: 294000 Open source
20062006-06-30	Free cash flow	-32287000	Operating Cash Flow: -31819000 Open source Capital Expenditure: 468000 Open source
20072007-06-30	Free cash flow	-24068000	Operating Cash Flow: -23544000 Open source Capital Expenditure: 524000 Open source
20082008-06-30	Free cash flow	-22292000	Operating Cash Flow: -22105000 Open source Capital Expenditure: 187000 Open source
20092009-06-30	Free cash flow	-8256000	Operating Cash Flow: -8175000 Open source Capital Expenditure: 81000 Open source
20102010-06-30	Free cash flow	-15692000	Operating Cash Flow: -15468000 Open source Capital Expenditure: 224000 Open source
20112011-06-30	Free cash flow	-23421000	Operating Cash Flow: -22271000 Open source Capital Expenditure: 1150000 Open source
20122012-06-30	Free cash flow	83112000	Operating Cash Flow: 86087000 Open source Capital Expenditure: 2975000 Open source
20142013-12-31	Free cash flow	70454000	Operating Cash Flow: 88772000 Open source Capital Expenditure: 18318000 Open source
20152014-12-31	Free cash flow	169848000	Operating Cash Flow: 183767000 Open source Capital Expenditure: 13919000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

21.8% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-09-12	Liabilities / assets	Not reported	Total Liabilities: 4570000 Open source
20062006-06-30	Liabilities / assets	Not reported	Total Liabilities: 3409000 Open source
20072007-06-30	Liabilities / assets	Not reported	Total Liabilities: 2694000 Open source
20082008-06-30	Liabilities / assets	Not reported	Total Liabilities: 1922000 Open source
20092009-06-30	Liabilities / assets	109.5%	Total Liabilities: 20042000 Open source Total Assets: 18301000 Open source
20102010-06-30	Liabilities / assets	13.1%	Total Liabilities: 10059000 Open source Total Assets: 76820000 Open source
20112011-06-30	Liabilities / assets	12.6%	Total Liabilities: 14678000 Open source Total Assets: 116352000 Open source
20122012-06-30	Liabilities / assets	39.7%	Total Liabilities: 86997000 Open source Total Assets: 219120000 Open source
20142013-12-31	Liabilities / assets	18.4%	Total Liabilities: 141128000 Open source Total Assets: 768751000 Open source
20152014-12-31	Liabilities / assets	21.8%	Total Liabilities: 230942000 Open source Total Assets: 1060107000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.23× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-09-12	Current assets / current liabilities	16.35×	Current Assets: 73153000 Open source Current Liabilities: 4473000 Open source
20062006-06-30	Current assets / current liabilities	12.41×	Current Assets: 41438000 Open source Current Liabilities: 3339000 Open source
20072007-06-30	Current assets / current liabilities	15.19×	Current Assets: 39723000 Open source Current Liabilities: 2615000 Open source
20082008-06-30	Current assets / current liabilities	9.27×	Current Assets: 17156000 Open source Current Liabilities: 1851000 Open source
20092009-06-30	Current assets / current liabilities	1.14×	Current Assets: 17541000 Open source Current Liabilities: 15372000 Open source
20102010-06-30	Current assets / current liabilities	7.6×	Current Assets: 76045000 Open source Current Liabilities: 10009000 Open source
20112011-06-30	Current assets / current liabilities	8.04×	Current Assets: 114696000 Open source Current Liabilities: 14268000 Open source
20122012-06-30	Current assets / current liabilities	11.24×	Current Assets: 213395000 Open source Current Liabilities: 18986000 Open source
20142013-12-31	Current assets / current liabilities	8.45×	Current Assets: 740801000 Open source Current Liabilities: 87631000 Open source
20152014-12-31	Current assets / current liabilities	5.23×	Current Assets: 1015559000 Open source Current Liabilities: 194236000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2004-09-13 – 2005-09-12	−USD 31.05 million Exact value Exact value: -31048000 USD 2004-09-13 – 2005-09-12: -31048000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2005-09-12 PHARMACYCLICS INC (edgar:949699) Net Income: -31048000 USD Concept: fundies:NetIncome Period: 2004-09-13 to 2005-09-12 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2005-09-12&surface=latest&period_type=duration&start=2004-09-13&unit=USD&dimensions= Input fundies:NetIncome: -31048000 USD (2004-09-13 to 2005-09-12) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-05-000059.txt#4007 The citation records this snapshot. The page link may show a newer release later.	−USD 29.93 million Exact value Exact value: -29930000 USD 2004-09-13 – 2005-09-12: -29930000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2005-09-12 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: -29930000 USD Concept: fundies:OperatingCashFlow Period: 2004-09-13 to 2005-09-12 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2005-09-12&surface=latest&period_type=duration&start=2004-09-13&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29930000 USD (2004-09-13 to 2005-09-12) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-05-000059.txt#4020 The citation records this snapshot. The page link may show a newer release later.	USD 294,000 Exact value Exact value: 294000 USD 2004-09-13 – 2005-09-12: 294000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2005-09-12 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 294000 USD Concept: fundies:CapitalExpenditure Period: 2004-09-13 to 2005-09-12 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2005-09-12&surface=latest&period_type=duration&start=2004-09-13&unit=USD&dimensions= Input fundies:CapitalExpenditure: 294000 USD (2004-09-13 to 2005-09-12) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-05-000059.txt#4023 The citation records this snapshot. The page link may show a newer release later.	−USD 30.22 million Calculation and evidence -29930000 − 294000 USD Exact free cash flow: -30224000 USD 2004-09-13 – 2005-09-12: -29930000 USD · Inspect Operating Cash Flow · Source 2004-09-13 – 2005-09-12: 294000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2005-09-12 PHARMACYCLICS INC (edgar:949699) Free cash flow: -30224000 USD Concept: free-cash-flow Period: 2004-09-13 to 2005-09-12 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29930000 USD (2004-09-13 to 2005-09-12) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-05-000059.txt#4020 Input fundies:CapitalExpenditure: 294000 USD (2004-09-13 to 2005-09-12) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-05-000059.txt#4023 The citation records this snapshot. The page link may show a newer release later.
2006 2005-07-01 – 2006-06-30	−USD 42.16 million Exact value Exact value: -42158000 USD 2005-07-01 – 2006-06-30: -42158000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2006-06-30 PHARMACYCLICS INC (edgar:949699) Net Income: -42158000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: -42158000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-08-000025.txt#4388 The citation records this snapshot. The page link may show a newer release later.	−USD 31.82 million Exact value Exact value: -31819000 USD 2005-07-01 – 2006-06-30: -31819000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2006-06-30 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: -31819000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31819000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-08-000025.txt#4403 The citation records this snapshot. The page link may show a newer release later.	USD 468,000 Exact value Exact value: 468000 USD 2005-07-01 – 2006-06-30: 468000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2006-06-30 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 468000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 468000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-08-000025.txt#4406 The citation records this snapshot. The page link may show a newer release later.	−USD 32.29 million Calculation and evidence -31819000 − 468000 USD Exact free cash flow: -32287000 USD 2005-07-01 – 2006-06-30: -31819000 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 468000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2006-06-30 PHARMACYCLICS INC (edgar:949699) Free cash flow: -32287000 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31819000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-08-000025.txt#4403 Input fundies:CapitalExpenditure: 468000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000949699-08-000025.txt#4406 The citation records this snapshot. The page link may show a newer release later.
2007 2006-07-01 – 2007-06-30	−USD 26.22 million Exact value Exact value: -26217000 USD 2006-07-01 – 2007-06-30: -26217000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2007-06-30 PHARMACYCLICS INC (edgar:949699) Net Income: -26217000 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: -26217000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0001136261-09-000278.txt#8517 The citation records this snapshot. The page link may show a newer release later.	−USD 23.54 million Exact value Exact value: -23544000 USD 2006-07-01 – 2007-06-30: -23544000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2007-06-30 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: -23544000 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23544000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0001136261-09-000278.txt#9029 The citation records this snapshot. The page link may show a newer release later.	USD 524,000 Exact value Exact value: 524000 USD 2006-07-01 – 2007-06-30: 524000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2007-06-30 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 524000 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 524000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0001136261-09-000278.txt#9121 The citation records this snapshot. The page link may show a newer release later.	−USD 24.07 million Calculation and evidence -23544000 − 524000 USD Exact free cash flow: -24068000 USD 2006-07-01 – 2007-06-30: -23544000 USD · Inspect Operating Cash Flow · Source 2006-07-01 – 2007-06-30: 524000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2007-06-30 PHARMACYCLICS INC (edgar:949699) Free cash flow: -24068000 USD Concept: free-cash-flow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23544000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0001136261-09-000278.txt#9029 Input fundies:CapitalExpenditure: 524000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0001136261-09-000278.txt#9121 The citation records this snapshot. The page link may show a newer release later.
2008 2007-07-01 – 2008-06-30	−USD 24.3 million Exact value Exact value: -24298000 USD 2007-07-01 – 2008-06-30: -24298000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2008-06-30 PHARMACYCLICS INC (edgar:949699) Net Income: -24298000 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:NetIncome: -24298000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-10-001360.txt#9725 The citation records this snapshot. The page link may show a newer release later.	−USD 22.11 million Exact value Exact value: -22105000 USD 2007-07-01 – 2008-06-30: -22105000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2008-06-30 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: -22105000 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22105000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-10-001360.txt#10085 The citation records this snapshot. The page link may show a newer release later.	USD 187,000 Exact value Exact value: 187000 USD 2007-07-01 – 2008-06-30: 187000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2008-06-30 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 187000 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 187000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-10-001360.txt#10143 The citation records this snapshot. The page link may show a newer release later.	−USD 22.29 million Calculation and evidence -22105000 − 187000 USD Exact free cash flow: -22292000 USD 2007-07-01 – 2008-06-30: -22105000 USD · Inspect Operating Cash Flow · Source 2007-07-01 – 2008-06-30: 187000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2008-06-30 PHARMACYCLICS INC (edgar:949699) Free cash flow: -22292000 USD Concept: free-cash-flow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22105000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-10-001360.txt#10085 Input fundies:CapitalExpenditure: 187000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-10-001360.txt#10143 The citation records this snapshot. The page link may show a newer release later.
2009 2008-07-01 – 2009-06-30	−USD 23.45 million Exact value Exact value: -23447000 USD 2008-07-01 – 2009-06-30: -23447000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2009-06-30 PHARMACYCLICS INC (edgar:949699) Net Income: -23447000 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: -23447000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-11-001781.txt#7656 The citation records this snapshot. The page link may show a newer release later.	−USD 8.18 million Exact value Exact value: -8175000 USD 2008-07-01 – 2009-06-30: -8175000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2009-06-30 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: -8175000 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8175000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-11-001781.txt#8016 The citation records this snapshot. The page link may show a newer release later.	USD 81,000 Exact value Exact value: 81000 USD 2008-07-01 – 2009-06-30: 81000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2009-06-30 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 81000 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 81000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-11-001781.txt#8074 The citation records this snapshot. The page link may show a newer release later.	−USD 8.26 million Calculation and evidence -8175000 − 81000 USD Exact free cash flow: -8256000 USD 2008-07-01 – 2009-06-30: -8175000 USD · Inspect Operating Cash Flow · Source 2008-07-01 – 2009-06-30: 81000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2009-06-30 PHARMACYCLICS INC (edgar:949699) Free cash flow: -8256000 USD Concept: free-cash-flow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8175000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-11-001781.txt#8016 Input fundies:CapitalExpenditure: 81000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/0000921895-11-001781.txt#8074 The citation records this snapshot. The page link may show a newer release later.
2010 2009-07-01 – 2010-06-30	−USD 15.02 million Exact value Exact value: -15024000 USD 2009-07-01 – 2010-06-30: -15024000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2010-06-30 PHARMACYCLICS INC (edgar:949699) Net Income: -15024000 USD Concept: fundies:NetIncome Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:NetIncome: -15024000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530513000345/pcyc-20121231.xml#853503 Filing: 000144530513000345 The citation records this snapshot. The page link may show a newer release later.	−USD 15.47 million Exact value Exact value: -15468000 USD 2009-07-01 – 2010-06-30: -15468000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2010-06-30 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: -15468000 USD Concept: fundies:OperatingCashFlow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15468000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530513000345/pcyc-20121231.xml#852595 Filing: 000144530513000345 The citation records this snapshot. The page link may show a newer release later.	USD 224,000 Exact value Exact value: 224000 USD 2009-07-01 – 2010-06-30: 224000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2010-06-30 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 224000 USD Concept: fundies:CapitalExpenditure Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 224000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530513000345/pcyc-20121231.xml#883894 Filing: 000144530513000345 The citation records this snapshot. The page link may show a newer release later.	−USD 15.69 million Calculation and evidence -15468000 − 224000 USD Exact free cash flow: -15692000 USD 2009-07-01 – 2010-06-30: -15468000 USD · Inspect Operating Cash Flow · Source 2009-07-01 – 2010-06-30: 224000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2010-06-30 PHARMACYCLICS INC (edgar:949699) Free cash flow: -15692000 USD Concept: free-cash-flow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15468000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530513000345/pcyc-20121231.xml#852595 Filing: 000144530513000345 Input fundies:CapitalExpenditure: 224000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530513000345/pcyc-20121231.xml#883894 Filing: 000144530513000345 The citation records this snapshot. The page link may show a newer release later.
2011 2010-07-01 – 2011-06-30	−USD 35.2 million Exact value Exact value: -35203000 USD 2010-07-01 – 2011-06-30: -35203000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2011-06-30 PHARMACYCLICS INC (edgar:949699) Net Income: -35203000 USD Concept: fundies:NetIncome Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:NetIncome: -35203000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530514000625/pcyc-20131231.xml#930583 Filing: 000144530514000625 The citation records this snapshot. The page link may show a newer release later.	−USD 22.27 million Exact value Exact value: -22271000 USD 2010-07-01 – 2011-06-30: -22271000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2011-06-30 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: -22271000 USD Concept: fundies:OperatingCashFlow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22271000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530514000625/pcyc-20131231.xml#929560 Filing: 000144530514000625 The citation records this snapshot. The page link may show a newer release later.	USD 1.15 million Exact value Exact value: 1150000 USD 2010-07-01 – 2011-06-30: 1150000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2011-06-30 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 1150000 USD Concept: fundies:CapitalExpenditure Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1150000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530514000625/pcyc-20131231.xml#958567 Filing: 000144530514000625 The citation records this snapshot. The page link may show a newer release later.	−USD 23.42 million Calculation and evidence -22271000 − 1150000 USD Exact free cash flow: -23421000 USD 2010-07-01 – 2011-06-30: -22271000 USD · Inspect Operating Cash Flow · Source 2010-07-01 – 2011-06-30: 1150000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2011-06-30 PHARMACYCLICS INC (edgar:949699) Free cash flow: -23421000 USD Concept: free-cash-flow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22271000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530514000625/pcyc-20131231.xml#929560 Filing: 000144530514000625 Input fundies:CapitalExpenditure: 1150000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000144530514000625/pcyc-20131231.xml#958567 Filing: 000144530514000625 The citation records this snapshot. The page link may show a newer release later.
2012 2011-07-01 – 2012-06-30	USD 11.99 million Exact value Exact value: 11986000 USD 2011-07-01 – 2012-06-30: 11986000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2012-06-30 PHARMACYCLICS INC (edgar:949699) Net Income: 11986000 USD Concept: fundies:NetIncome Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:NetIncome: 11986000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#419083 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 86.09 million Exact value Exact value: 86087000 USD 2011-07-01 – 2012-06-30: 86087000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2012-06-30 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: 86087000 USD Concept: fundies:OperatingCashFlow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 86087000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#417894 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 2.98 million Exact value Exact value: 2975000 USD 2011-07-01 – 2012-06-30: 2975000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2012-06-30 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 2975000 USD Concept: fundies:CapitalExpenditure Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2975000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433136 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 83.11 million Calculation and evidence 86087000 − 2975000 USD Exact free cash flow: 83112000 USD 2011-07-01 – 2012-06-30: 86087000 USD · Inspect Operating Cash Flow · Source 2011-07-01 – 2012-06-30: 2975000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2012-06-30 PHARMACYCLICS INC (edgar:949699) Free cash flow: 83112000 USD Concept: free-cash-flow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 86087000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#417894 Filing: 000162828015000826 Input fundies:CapitalExpenditure: 2975000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433136 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.
2014 2013-01-01 – 2013-12-31	USD 67.01 million Exact value Exact value: 67010000 USD 2013-01-01 – 2013-12-31: 67010000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2013-12-31 PHARMACYCLICS INC (edgar:949699) Net Income: 67010000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 67010000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#420069 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 88.77 million Exact value Exact value: 88772000 USD 2013-01-01 – 2013-12-31: 88772000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2013-12-31 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: 88772000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 88772000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#418104 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 18.32 million Exact value Exact value: 18318000 USD 2013-01-01 – 2013-12-31: 18318000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2013-12-31 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 18318000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18318000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433345 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 70.45 million Calculation and evidence 88772000 − 18318000 USD Exact free cash flow: 70454000 USD 2013-01-01 – 2013-12-31: 88772000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 18318000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2013-12-31 PHARMACYCLICS INC (edgar:949699) Free cash flow: 70454000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 88772000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#418104 Filing: 000162828015000826 Input fundies:CapitalExpenditure: 18318000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433345 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.
2015 2014-01-01 – 2014-12-31	USD 86.12 million Exact value Exact value: 86124000 USD 2014-01-01 – 2014-12-31: 86124000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Net Income: 86124000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 86124000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#421057 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 183.77 million Exact value Exact value: 183767000 USD 2014-01-01 – 2014-12-31: 183767000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Operating Cash Flow: 183767000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 183767000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#418315 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 13.92 million Exact value Exact value: 13919000 USD 2014-01-01 – 2014-12-31: 13919000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Capital Expenditure: 13919000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13919000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433556 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.	USD 169.85 million Calculation and evidence 183767000 − 13919000 USD Exact free cash flow: 169848000 USD 2014-01-01 – 2014-12-31: 183767000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 13919000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACYCLICS INC · 2014-12-31 PHARMACYCLICS INC (edgar:949699) Free cash flow: 169848000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:07:07Z Snapshot: 9aa321f1abc3733ffe9a8d2ddb1a70952e7200fca98ec9b79fc0fd61d8966265 Dimensions: Consolidated View: https://fundies.io/companies/edgar/949699?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 183767000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#418315 Filing: 000162828015000826 Input fundies:CapitalExpenditure: 13919000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/949699/000162828015000826/pcyc-20141231.xml#433556 Filing: 000162828015000826 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

89 filings · 1,513 latest values · 1,513 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000949699, 949699, edgar:949699

Also known as PHARMACYCLICS INC

PHARMACYCLICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation